30206302|t|Particular CSF sphingolipid patterns identify iNPH and AD patients.
30206302|a|Idiopathic normal pressure hydrocephalus (iNPH) is characterized by reversible neurological symptoms due to an impairment in cerebrospinal fluid (CSF) clearance. In these patients, cognitive functions are severely impaired, with a scenario similar to Alzheimer's disease (AD), making the differential diagnosis difficult and highlighting the need of new markers. We analyzed the composition of sphingolipids (SLs) in serum, by combining a single phase extraction with a high-performance thin-layer chromatography (HPTLC) primuline-profiling, and, in CSF, by MALDI profiling and LC-MS. Ceramides and sphingomyelins (SMs) were similar in serum of iNPH and AD patients compared to healthy controls, whereas, in CSF, MALDI profiling indicated that: 1) SM C24:1 is significantly decreased in AD compared to iNPH patients and controls (Kruskal-Wallis p-value < 0.00001); 2) phosphatidylcholine (PC) 36:2 is increased in iNPH patients (p-value < 0.001). LC-MS identified an increasing trend of Cer C24:0 and of a set of SMs in patients with AD, a significant decrease of sphingosine-1-phosphate (S1P) (t-test p-value 0.0325) and an increase of glucosylceramide (GlcCer) C24:0 (p-value 0.0037) in AD compared to iNPH patients. In conclusion CSF PC 36:2, SM C24:1, S1P, and GlcCer can contribute to improve the differential diagnosis of patients with iNPH or AD and foster preventive therapeutic strategies in the early phase of the disease.
30206302	15	27	sphingolipid	Chemical	MESH:D013107
30206302	46	50	iNPH	Disease	MESH:D006850
30206302	55	57	AD	Disease	MESH:D000544
30206302	58	66	patients	Species	9606
30206302	68	108	Idiopathic normal pressure hydrocephalus	Disease	MESH:D006850
30206302	110	114	iNPH	Disease	MESH:D006850
30206302	147	168	neurological symptoms	Disease	MESH:D009461
30206302	239	247	patients	Species	9606
30206302	319	338	Alzheimer's disease	Disease	MESH:D000544
30206302	340	342	AD	Disease	MESH:D000544
30206302	462	475	sphingolipids	Chemical	MESH:D013107
30206302	477	480	SLs	Chemical	MESH:D013107
30206302	653	662	Ceramides	Chemical	MESH:D002518
30206302	667	681	sphingomyelins	Chemical	MESH:D013109
30206302	683	686	SMs	Chemical	MESH:D013109
30206302	713	717	iNPH	Disease	MESH:D006850
30206302	722	724	AD	Disease	MESH:D000544
30206302	725	733	patients	Species	9606
30206302	816	824	SM C24:1	Chemical	-
30206302	855	857	AD	Disease	MESH:D000544
30206302	870	874	iNPH	Disease	MESH:D006850
30206302	875	883	patients	Species	9606
30206302	936	965	phosphatidylcholine (PC) 36:2	Chemical	-
30206302	982	986	iNPH	Disease	MESH:D006850
30206302	987	995	patients	Species	9606
30206302	1055	1058	Cer	Chemical	-
30206302	1081	1084	SMs	Chemical	MESH:D013109
30206302	1088	1096	patients	Species	9606
30206302	1102	1104	AD	Disease	MESH:D000544
30206302	1132	1155	sphingosine-1-phosphate	Chemical	MESH:C060506
30206302	1157	1160	S1P	Chemical	MESH:C060506
30206302	1205	1221	glucosylceramide	Chemical	MESH:D005963
30206302	1223	1229	GlcCer	Chemical	MESH:D005963
30206302	1257	1259	AD	Disease	MESH:D000544
30206302	1272	1276	iNPH	Disease	MESH:D006850
30206302	1277	1285	patients	Species	9606
30206302	1305	1312	PC 36:2	Chemical	-
30206302	1314	1322	SM C24:1	Chemical	-
30206302	1333	1339	GlcCer	Chemical	MESH:D005963
30206302	1396	1404	patients	Species	9606
30206302	1410	1414	iNPH	Disease	MESH:D006850
30206302	1418	1420	AD	Disease	MESH:D000544
30206302	Association	MESH:C060506	MESH:D000544
30206302	Positive_Correlation	MESH:D005963	MESH:D000544
30206302	Association	MESH:D005963	MESH:D006850
30206302	Association	MESH:D013107	MESH:D000544
30206302	Association	MESH:D013107	MESH:D006850
30206302	Association	MESH:C060506	MESH:D006850
30206302	Association	MESH:D013109	MESH:D000544

